» Articles » PMID: 39717077

Impact of the Acti-Pair Programme on Physical Activity in Patients with Prostate Cancer: Protocol of the Acti-Pair 2 Stepped-wedge Cluster Randomised Trial

Overview
Specialty Orthopedics
Date 2024 Dec 24
PMID 39717077
Authors
Affiliations
Soon will be listed here.
Abstract

Regular physical activity (PA) reduces morbidity and mortality in prostate cancer. Prescribing PA in cancer is a necessary awareness but is a real challenge in the case of prostate cancer. Motivational peer support seems to be an innovative strategy for lifestyle change. Therefore, we developed the Acti-Pair programme and demonstrated its feasibility. We want to evaluate its effectiveness in promoting PA in patients with prostate cancer. The Acti-Pair 2 study is an interventional, comparative, multicentre, randomised, stepped-wedge cluster study. The control group will consist of patients being followed for prostate cancer and receiving advice and recommendations for PA during consultations to make patients more active in their daily lives (=usual practice, PA to be performed independently at home). The intervention group will consist of patients being followed up for prostate cancer and benefiting from the Acti-Pair programme, which combines three interventions: (1) motivational support from a peer; (2) construction of a personalised and realistic project and (3) support from health and adapted PA professionals. This study will assess the effectiveness, implementation and efficiency of the Acti-Pair programme. It will allow the identification of key success factors for implementing the Acti-Pair programme to prepare for its transferability. Trial registration number: Clinical trial, NCT05739565, registered on 20 February 2023, https://clinicaltrials.gov/study/NCT05739565..

References
1.
Nadler M, Bainbridge D, Tomasone J, Cheifetz O, Juergens R, Sussman J . Oncology care provider perspectives on exercise promotion in people with cancer: an examination of knowledge, practices, barriers, and facilitators. Support Care Cancer. 2017; 25(7):2297-2304. DOI: 10.1007/s00520-017-3640-9. View

2.
Baudot A, Barth N, Colas C, Garros M, Garcin A, Oriol M . The physical activity experience of prostate cancer patients: a multicentre peer motivation monitoring feasibility study. The Acti-Pair study. Pilot Feasibility Stud. 2022; 8(1):12. PMC: 8781045. DOI: 10.1186/s40814-022-00966-9. View

3.
Steindorf K, Depenbusch J, Haussmann A, Tsiouris A, Schmidt L, Hermann S . Change patterns and determinants of physical activity differ between breast, prostate, and colorectal cancer patients. Support Care Cancer. 2019; 28(7):3207-3218. DOI: 10.1007/s00520-019-05097-1. View

4.
Bonn S, Sjolander A, Trolle Lagerros Y, Wiklund F, Stattin P, Holmberg E . Physical activity and survival among men diagnosed with prostate cancer. Cancer Epidemiol Biomarkers Prev. 2014; 24(1):57-64. DOI: 10.1158/1055-9965.EPI-14-0707. View

5.
Bourke L, Turner R, Greasley R, Sutton E, Steed L, Smith D . A multi-centre investigation of delivering national guidelines on exercise training for men with advanced prostate cancer undergoing androgen deprivation therapy in the UK NHS. PLoS One. 2018; 13(7):e0197606. PMC: 6033384. DOI: 10.1371/journal.pone.0197606. View